Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Epigenetics in Drug Discovery

Paul Bamborough's Biography



Paul Bamborough, Computational Chemistry Section Head, GlaxoSmithKline

Paul studied chemistry and completed a D.Phil. at Oxford University. After a post-doc at the University of California, San Francisco, he joined the computer-aided drug design group at Rhône-Poulenc Rorer before moving to GlaxoSmithKline in 1999. He leads a computational chemistry group and cross-functional program teams including ATAD2, but still likes to get hands-on with drug discovery targets, especially epigenetic and kinase gene families.

Paul Bamborough Image

Playing the System: Finding Selective Chemical Probes for Bromodomain Epigenetic Readers

Wednesday, 27 January 2016 at 14:00

Add to Calendar ▼2016-01-27 14:00:002016-01-27 15:00:00Europe/LondonPlaying the System: Finding Selective Chemical Probes for Bromodomain Epigenetic ReadersEpigenetics in Drug Discovery in Cambridge, UKCambridge, UKSELECTBIOenquiries@selectbiosciences.com

This presentation describes examples of using structural, computational and medicinal chemistry to find potent and selective inhibitors of untargeted non-BET family bromodomains.


Add to Calendar ▼2016-01-26 00:00:002016-01-27 00:00:00Europe/LondonEpigenetics in Drug DiscoveryEpigenetics in Drug Discovery in Cambridge, UKCambridge, UKSELECTBIOenquiries@selectbiosciences.com